This session will highlight challenges with caring for members with OUD during the pandemic and discuss strategies to ensure comprehensive, coordinated longitudinal care for those impacted by OUD.

This session will review recent OPM initiatives on coverage for fertility preservation for those at risk of infertility from medical treatments and initiatives on the coverage of medical foods.

As OPM considers how to incorporate this critical aspect of quality care into the Plan Performance Assessment, this session will highlight why OPM is committed to the design of meaningful actions within the FEHB that will reduce unnecessary costs to the government and enrollees.

The session will review the rapid recent expansion of telehealth services during the National Health Emergency, technological innovations that may make telehealth services more useful, and options for preserving the coverage of these services once social distancing guidelines are removed.

In this session, federal leaders will discuss key regulatory initiatives that are reshaping technology expectations for health insurers and enabling the digital reporting of quality measures.

High-cost drugs under the pharmacy and medical benefit increasingly account for a significant proportion of overall health care spending. This session will highlight multiple strategies to manage high-cost drugs while ensuring affordability and maintaining access to innovative therapies.

This session will highlight best practices for engaging members, addressing vaccine confidence and health equity.

This session will review current developments in this field, facilitate a discussion on different payment approaches (e.g., value-based, single lump sum, amortized) and highlight the significant cost implications of these new therapies.

This session will provide an update on operational changes/enhancements and initiatives (Master Enrollment Index and Central Enrollment Program) OPM is taking to improve the enrollment process.

This session will highlight medication management programs and how FEHB Carriers can successfully implement a medication management program to ensure safe and optimal medication use.

This session will present an overview of new guidance published on FEHB family member eligibility. The session will cover agency and Carrier responsibilities for removing ineligible family member as well as verifying family member eligibility during the initial opportunity to enroll and qualifying life events.

This session will focus on lessons from FEHB Carriers’ preliminary efforts, as well as a discussion of OPM’s interest in this area.

As the most widely accessible health care provider, enhancing engagement of the pharmacist as a critical member of the health care team can increase access to preventive services and support population health initiatives. This session will describe integration strategies, available tools, and resources to improve service delivery and mitigate barriers and highlight case examples of pharmacists’ engagement through the lens of tobacco cessation treatment.

This session will review examples of Alternative Payment Models from both the payer and stakeholder perspective, as well as successes and challenges.

Each year, FEHB Carriers receive the Detailed Performance Summary Report, showing how they performed in reference to other FEHB Carriers. This session will provide an overview of the information within these reports. The PPA team will also provide data highlights from the 2020 Scoring Cycle. In addition, OPM will discuss Carrier performance improvement input.